Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FR8XC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,493
Award facts
- Contract value 100% obligated
- $22,492.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,492.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a non-set-aside award with a completion date of January 8, 2026, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 single-award vehicle running through December 31, 2031, that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The Repatha supply supports DLA's mission to sustain military readiness by providing essential medications, in this case a specialty cardiovascular treatment used for cholesterol management. The company's federal contract portfolio demonstrates extensive experience delivering diverse pharmaceutical products across multiple therapeutic domains through competitively awarded firm fixed-price delivery orders, positioning it as a key provider within the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FR8XC?
SPE2DR26FR8XC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FR8XC worth?
The government has obligated $22,493 on SPE2DR26FR8XC.
Is contract SPE2DR26FR8XC an order under another contract?
Yes. SPE2DR26FR8XC is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8XC competed?
The extent of competition for SPE2DR26FR8XC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award